Pediatric and Maternal Health Product Development
Division Director: Lynne Yao, M.D.
Deputy Director: John Alexander, M.D., MPH
The Division of Pediatric and Maternal Health (DPMH) is located in the Office of New Drugs. DPMH oversees quality initiatives which promote and necessitate the study of drug and biological products in the pediatric population and to improve pregnancy and lactation-related information in product labeling.
What is DPMH’s Role?
To collaborate to develop clinically relevant, evidence-based labeling and other communications that facilitate informed use of medicines in children, pregnant females, lactating females, and females and males of reproductive potential.
Food and Drug Administration
Center for Drug Evaluation and Research
Office of New Drugs
10903 New Hampshire Avenue
Silver Spring, MD 20993
Main Line: 301-796-2200